BACKGROUND: Schizobipolar disorder is considered related to both schizophrenia and bipolar disorder. We aimed to describe with retrospective methodology the demographic, clinical, and treatment features in a group of schizobipolar disorder patients who have been treated for at least a 5-year period and compare them with bipolar I and schizophrenic patients who were treated during the same period. METHOD: We compared the demographic and clinical data of 61 schizobipolar, 57 bipolar I, and 55 schizophrenic outpatients who were diagnosed and treated for at least 5 years in the outpatient clinic in the Federal University of Rio de Janeiro. RESULTS: The schizobipolar disorder patients had a profile similar to the bipolar I patients but are significantly different from schizophrenic patients in educational level, marital status, occupation, drug and alcohol abuse episodes, presence of depressive, mixed and maniac episodes, family history of bipolar I and mood disorders, and use of medications. Only the age of onset, suicide attempts, and family history of suicide are not significantly different among the groups. The schizophrenic patients used antipsychotics for more days and the schizobipolar and bipolar I used more antidepressants and mood stabilizers. 37 (60.6%) schizobipolar patients had their diagnosis changed to bipolar disorder by their physician in different periods during the period studied. LIMITATIONS: It is a retrospective data description based on a naturalistic treatment. The family history was collected from the patient and whenever possible from one first-degree relative. CONCLUSION: Schizobipolar disorder patients have demographic, clinical and therapeutic features similar to bipolar I patients and data support its definite inclusion in the bipolar spectrum group.
BACKGROUND:Schizobipolar disorder is considered related to both schizophrenia and bipolar disorder. We aimed to describe with retrospective methodology the demographic, clinical, and treatment features in a group of schizobipolar disorderpatients who have been treated for at least a 5-year period and compare them with bipolar I and schizophrenicpatients who were treated during the same period. METHOD: We compared the demographic and clinical data of 61 schizobipolar, 57 bipolar I, and 55 schizophrenic outpatients who were diagnosed and treated for at least 5 years in the outpatient clinic in the Federal University of Rio de Janeiro. RESULTS: The schizobipolar disorderpatients had a profile similar to the bipolar Ipatients but are significantly different from schizophrenicpatients in educational level, marital status, occupation, drug and alcohol abuse episodes, presence of depressive, mixed and maniac episodes, family history of bipolar I and mood disorders, and use of medications. Only the age of onset, suicide attempts, and family history of suicide are not significantly different among the groups. The schizophrenicpatients used antipsychotics for more days and the schizobipolar and bipolar I used more antidepressants and mood stabilizers. 37 (60.6%) schizobipolar patients had their diagnosis changed to bipolar disorder by their physician in different periods during the period studied. LIMITATIONS: It is a retrospective data description based on a naturalistic treatment. The family history was collected from the patient and whenever possible from one first-degree relative. CONCLUSION:Schizobipolar disorderpatients have demographic, clinical and therapeutic features similar to bipolar Ipatients and data support its definite inclusion in the bipolar spectrum group.
Authors: Alessandra Benedetti; Stefano Pini; Giovanni DE Girolamo; Carmen Berrocal; Antonio Tundo; Pierluigi Morosini; Giovanni Battista Cassano Journal: World Psychiatry Date: 2009-06 Impact factor: 49.548
Authors: G Studentkowski; D Scheele; P Calabrese; F Balkau; J Höffler; T Aubel; M-A Edel; G Juckel; Hans-Jörg Assion Journal: Eur J Med Res Date: 2010-02-26 Impact factor: 2.175
Authors: M Kataoka; N Matoba; T Sawada; A-A Kazuno; M Ishiwata; K Fujii; K Matsuo; A Takata; T Kato Journal: Mol Psychiatry Date: 2016-05-24 Impact factor: 15.992